Clinical Trial

A Prospective Study Using SupraSDRM® in Promoting Healing and Reducing the Time to Grafting of Full-thickness Wounds

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, randomized, controlled, multi-center clinical study comparing SupraSDRM® to standard of care wound dressing, BTM, in the treatment of full-thickness wounds deemed not immediately suitable for definitive grafting will be performed.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-08-14
notable Primary completion pushed: 2025-10 -> 2027-12 2026-08-14
minor Completion pushed: 2026-10 -> 2027-12 2026-08-14
Trial Details
NCT Number NCT06503406
Lead Sponsor The Metis Foundation
Collaborators: The University of Texas Medical Branch, Galveston, United States Department of Defense, United States Army Institute of Surgical Research
Conditions Surgical Wound, Burns, Trauma Injury
Enrollment 24 participants
Start Date 2026-01-08
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-13